HOME >> BIOLOGY >> NEWS
Crack open an egg and cure a disease

WHY did the geneticist cross the chicken? To turn it into a cheap pharmaceuticals factory, it seems. Comical as it may sound, two companies are planning a pilot test of drugs in eggs laid by genetically engineered chickens.

GeneWorks of Ann Arbor, Michigan, announced this month that it has a flock of between 50 and 60 genetically engineered birds. Some carry a gene that enables them to make a human growth factor in their eggs, while others produce a human antibody.

Although the company will not name the proteins, it says that both have great potential for treating disease. According to its chief operating officer Steve Sensoli, GeneWorks has deals to make 14 proteins for six drug companies around the world.

Meanwhile, AviGenics of Athens, Georgia, has produced a human interferon for treating cancer in its flock of birds. It claims to have a slight lead on its rival because it has already managed to pass on the interferon gene to further generations of birds. With hens producing an average of 200 eggs each per year, and 100 milligrams or more of a drug in each egg, both companies believe the yields could be large and lucrative.

The companies smuggle genes into the birds using harmless forms of viruses that are engineered so they cannot replicate. The gene that makes the protein is inserted in the virus.

GeneWorks uses the reticulo endotheliosis virus as a ferry. The company uses a genetic switch that restricts production of the protein to the egg white. "We put it in a one-day-old chicken embryo by microinjecting it into a cavity called the blastoderm," explains Sensoli. He and his colleagues hope that some virus reaches primordial cells in the blastoderm which develop into sperm and eggs, so the gene for the protein can be passed down to future generations of chickens, rather than having to repeat the injection in each generation. But the company can already harvest the proteins from hens that have been injected and next year plans to open a
'"/>

Contact: Claire Bowles
claire.bowles@rbi.co.uk
44-20-7331-2751
New Scientist
9-Nov-1999


Page: 1 2

Related biology news :

1. Crack babies do better when placed with non-family caregivers
2. Researchers Take Major Step Toward Cracking Ebola Code
3. Schepens Eye Research Institute receives Roadmap grant to develop center for curing eye diseases
4. Alzheimers disease is not accelerated aging
5. New molecular link key to cellular proteins involved in cancer progression, other diseases
6. Wildlife Conservation Society hosts public symposium on human-wildlife diseases
7. University of Alberta researcher looks for clues to mysterious disease
8. Study explores gene transfer to modify underlying course of Alzheimers disease
9. Experimental drug shown to block mutant protein causing blood disease
10. Algal contact as a trigger for coral disease
11. Ecology of infectious diseases grants awarded

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/23/2020)... ... April 23, 2020 , ... Despite the current COVID-19 ... infrastructure products for the animal feed, human consumption, wastewater, and biotech sectors, and ... supply channels from overseas competitors have become weakened or shut down completely, new ...
(Date:4/22/2020)... ... April 21, 2020 , ... USDM Life Sciences ... compliance, announces a new managed service to improve quality management for regulated companies, ... and USDM Life Sciences (USDM) – Unify Compliance Cloud is a suite of ...
(Date:4/18/2020)... ... April 17, 2020 , ... ... uses magnetic nano-beads to isolate minute bacterial particles that cause diseases. Using ... and difficult-to-detect micro-particles such as those making up Ebola and coronaviruses. , ...
Breaking Biology News(10 mins):
(Date:5/15/2020)... ... May 14, 2020 , ... Children with defective heart valves ... before becoming adults. The reason: there are no heart valve prosthetics designed to ... Department of Defense has awarded Draper, Boston Children’s Hospital and Seattle Children’s Research ...
(Date:5/15/2020)... ... May 15, 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage biotechnology ... as Executive Chairman. Mr. Ganz will continue to lead Sentien’s Board of Directors, ... closely with CEO Brian Miller and Sentien’s management team. , Mr. Ganz ...
(Date:5/14/2020)... ... May 12, 2020 , ... ... research, is bringing together thousands of industry leaders, clinicians, research scientists, medical professionals ... plenary speakers, Carl June, MD, Director of the Center for Cellular Immunotherapies at ...
(Date:5/14/2020)... ... , ... Early stages of drug discovery often depend on ... the drug’s mechanism of action (MOA). Gene expression profiling technologies like RNA sequencing ... molecular pathways. This information can complement phenotypic readouts and can be used to ...
Breaking Biology Technology:
Cached News: